DAIC

APRIL 18, 2024

Based on continuous monitoring of early recurrence of atrial tachyarrhythmia immediately after patients have undergone atrial fibrillation ablation, Musat et al. Early recurrence of atrial tachyarrhythmia (ERAT) is commonly seen following catheter ablation of AF, with reported incidences of up to 61% in the first three months.

Atrial Fibrillation 111

Atrial Fibrillation Ablation Heart Rhythm Article 111

American College of Cardiology

FEBRUARY 19, 2025

Atrial fibrillation catheter ablation (AFCA) improved clinical outcomes compared with medical treatment alone, and early AFCA was associated with better outcomes than late AFCA, particularly decreased risk of heart failure (HF) hospitalization and atrial fibrillation (AFib) recurrence.

AFIB 67

AFIB Ablation Atrial Fibrillation Outcomes 67

CardiacWire

APRIL 5, 2025

Expanding the potential patient population for pulsed field ablation, results from the SINGLE SHOT CHAMPION study suggest PFA might be just as good as cryoballoon ablation for patients with paroxysmal AFib. PFA has shown advantages in procedure time and safety, but its effectiveness is unproven compared to cryoballoon ablation.

AFIB 59

AFIB Ablation Atrial Fibrillation Pulmonary 59

DAIC

DECEMBER 29, 2023

Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. The company now anticipates U.S.

Atrial Fibrillation 115

Atrial Fibrillation Ablation Atrial Flutter Blood Clot 115

HeartRhythm

APRIL 8, 2024

There is insufficient data assessing the regional differences in catheter ablation outcomes for atrial fibrillation (AF) in the United States.

Atrial Fibrillation 75

Atrial Fibrillation Ablation Outcomes Inpatient 75

HeartRhythm

MAY 15, 2024

With the exponential growth of catheter ablation (CA) for atrial fibrillation (AF), there is increasing interest in associated healthcare costs.

Atrial Fibrillation 72

Atrial Fibrillation Ablation Outcomes 72

The New England Journal of Medicine

APRIL 2, 2025

After atrial fibrillation ablation, left atrial appendage closure was associated with a lower risk of bleeding than oral anticoagulation and was noninferior to oral anticoagulation with respect to clinical outcomes at 36 months.

Atrial Fibrillation 74

Atrial Fibrillation Ablation Outcomes 74

DAIC

FEBRUARY 2, 2024

Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy Atrial Fibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. Biosense Webster's zero fluoroscopy workflow is the first and only such workflow available in a radiofrequency (RF) cardiac ablation device.

Ablation 105

Ablation Atrial Fibrillation AFIB Heart Rhythm 105

HeartRhythm

MARCH 10, 2025

Ablation index (AI)-guided pulmonary vein isolation (PVI) has enhanced procedural outcomes for atrial fibrillation (AF).1 1 However, patients with persistent AF present higher recurrence rates due to advanced atrial remodeling,2-3 represented by the left atrial low voltage area (LVA), compared to those with paroxysmal AF.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Pulmonary 40

HeartRhythm

SEPTEMBER 20, 2024

Data on long-term effects of catheter ablation versus antiarrhythmic drugs (AAD) on health-related quality of life (HRQoL) and atrial fibrillation (AF) burden are limited.

Quality of Life 81

Quality of Life Atrial Fibrillation Ablation Outcomes 81

DAIC

FEBRUARY 6, 2024

EGF mapping allows physicians to detect EGF sources and is designed to individualize ablation strategies based on underlying pathophysiologic mechanisms to potentially improve outcomes. By guiding ablation therapy, [EGF mapping] can enable clinicians to provide personalized, highly targeted treatment."

Ablation 104

Ablation Atrial Fibrillation AFIB Pulmonary 104

The New England Journal of Medicine

FEBRUARY 19, 2025

Among patients with ventricular tachycardia and ischemic cardiomyopathy, catheter ablation as an initial therapy led to a lower risk of adverse outcomes than antiarrhythmic drug therapy.

Tachycardia 71

Tachycardia Ablation Cardiomyopathy Outcomes 71

Frontiers in Cardiovascular Medicine

FEBRUARY 7, 2024

Background Efforts to maintain sinus rhythm in patients with persistent atrial fibrillation (PsAF) remain challenging, with suboptimal long-term outcomes. Methods All patients undergoing convergent PsAF ablation at our centre were retrospectively analysed.

Atrial Fibrillation 81

Atrial Fibrillation Ablation Document Obesity 81

Medical Xpress - Cardiology

MAY 18, 2024

In a study published in Heart Rhythm, researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham health care system, analyzed real-world clinical data to measure the impact of evidence-based best-practices on patient outcomes for the most common AF procedure: radiofrequency (RF)-based ablation.

Atrial Fibrillation 85

Atrial Fibrillation Best Practices Outcomes Heart Rhythm 85

American College of Cardiology

APRIL 10, 2025

Patients undergoing atrial fibrillation (AFib) ablation who were not properly anticoagulated and did not undergo preprocedural transesophageal echocardiogram (TEE) were significantly more likely to suffer from transient ischemic attack (TIA) or pulmonary embolism (PE).

Echocardiogram 53

Echocardiogram Ablation Atrial Fibrillation AFIB 53

Frontiers in Cardiovascular Medicine

JANUARY 31, 2024

Background Pulmonary vein isolation with wide antral ablation leads to better clinical outcomes for the treatment of atrial fibrillation, but the isolation lesion is invisible in conventional cryoballoon ablation.

Atrial Fibrillation 64

Atrial Fibrillation Ablation Pulmonary Outcomes 64

American College of Cardiology

NOVEMBER 26, 2024

What are the outcomes of patients referred for ventricular tachycardia (VT) ablation according to left ventricular ejection fraction (LVEF), tolerance of VT, and acute ablation outcome?

Ablation 63

Ablation Tachycardia Outcomes Article 63

Journal of Cardiovascular Electrophysiology

JANUARY 28, 2024

Abstract Introduction Some previous studies have reported that a first-step ethanol infusion into the vein of Marshall (EIVOM) with touch-up radiofrequency (RF) ablation can facilitate mitral isthmus (MI) block and improves the ablation outcomes in persistent atrial fibrillation (PeAF) patients. 0.78, p  = .006).

Atrial Fibrillation 75

Atrial Fibrillation Ablation Bicuspid/Mitral Tachycardia 75

Frontiers in Cardiovascular Medicine

JANUARY 16, 2024

Introduction Catheter ablation is an effective and safe strategy for treating atrial fibrillation patients. Nevertheless, studies on the long-term outcomes of catheter ablation in patients with dilated cardiomyopathy are limited. Among the catheter ablation group, 58.7% ( n  = 27) had persistent atrial fibrillation.

Atrial Fibrillation 64

Atrial Fibrillation Ablation Cardiomyopathy Heart Failure 64

American College of Cardiology

FEBRUARY 12, 2025

Additional rhythm-control strategies are frequently continued after index ablation for atrial fibrillation (AFib), according to a study published Feb. 12 in JACC: Clinical Electrophysiology.

Atrial Fibrillation 55

Atrial Fibrillation Ablation AFIB Electrophysiology 55

Frontiers in Cardiovascular Medicine

JANUARY 15, 2024

Background Catheter ablation (CA) for symptomatic atrial fibrillation (AF) offers the best outcomes for patients. Data were collected from the MPH AF Ablation Registry with the approval of the institutional research board. We present real-world 5-year follow-up data of AI-guided pulmonary vein isolation.

Ablation 64

Ablation Atrial Fibrillation BMI Arrhythmia 64

Frontiers in Cardiovascular Medicine

DECEMBER 14, 2023

Limited information exists regarding the effects of concurrent atrial flutter on the long-term outcomes of rhythm control. This study investigated the association between concurrent typical atrial flutter and cavotricuspid isthmus (CTI) ablation and the recurrence of atrial arrhythmia.

Atrial Flutter 64

Atrial Flutter Atrial Fibrillation Ablation Arrhythmia 64

American College of Cardiology

AUGUST 8, 2024

What are the patient characteristics, population rates, and 30-day outcomes of pulmonary vein isolation (PVI) in a nationwide sample of US adults aged >65 years?

Outcomes 60

Outcomes Ablation Pulmonary Article 60

American College of Cardiology

APRIL 16, 2025

In this weeks View, Dr. Eagle examines the effects on patients who have undergone pre-ablation transesophageal echocardiogram (TEE) versus those who have not.

Echocardiogram 55

Echocardiogram Aortic valve Ablation Aortic 55

Open Heart

SEPTEMBER 19, 2024

Background The value of empirical superior vena cava isolation (SVCI) following pulmonary vein isolation (PVI) to improve the efficacy of radiofrequency catheter ablation (RFCA) for paroxysmal atrial fibrillation (PAF) remains controversial. RFCA was guided by quantitative AI in both groups. vs 81.5%, p=0.02). 95% CI 0.19

Atrial Fibrillation 52

Atrial Fibrillation Ablation Atrial Flutter Coronary Artery Disease 52

HeartRhythm

APRIL 3, 2025

In the context of VT ablation, functional electroanatomic mapping techniques may help identify arrhythmogenic substrates in scarred and normal voltage areas.

Ablation 40

Ablation Outcomes Tachycardia 40

Frontiers in Cardiovascular Medicine

APRIL 10, 2025

IntroductionCardiac fibrosis influences atrial fibrillation (AF) progression and ablation outcomes, with late gadolinium enhancement (LGE) MRI providing a non-invasive tool to measure fibrosis distributions. vs. 1.10.3) and average Shannon entropy (0.770.06 and 0.810.03).

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outcomes Research 40

HeartRhythm

JUNE 30, 2024

The association between hospital and physician procedure volume outcome has not been well evaluated for atrial fibrillation (AF) ablation in contemporary practice.

Atrial Fibrillation 40

Atrial Fibrillation Ablation AFIB Outcomes 40

Heart BMJ

FEBRUARY 12, 2025

This study aimed to evaluate the temporal relationship between AA and HF onset, the association between HF and the success of radiofrequency ablation (RFA), and how HF influences outcomes in patients with AA. Methods In this single-centre retrospective cohort study, data from 3995 patients with ACHD were analysed.

Congenital Heart Disease 59

Congenital Heart Disease Congenital Heart Failure Arrhythmia 59

HeartRhythm

DECEMBER 27, 2023

Catheter ablation for AF is safe, and it is associated with better clinical outcomes as compared to medical therapy (2). However, there is limited data on clinical outcomes of patients with NAFLD undergoing catheter ablation for AF.

Ablation 45

Ablation Atrial Fibrillation Outcomes 45

HeartRhythm

MARCH 18, 2024

Earlier studies have shown regional variations in outcomes after invasive cardiovascular procedures (1). However, there is a paucity of such data concerning VT ablation in the United States.

Ablation 45

Ablation Outcomes Tachycardia Hospital 45

American College of Cardiology

NOVEMBER 16, 2024

Among patients with ischemic cardiomyopathy and ventricular tachycardia (VT), catheter ablation as a first-line strategy over antiarrhythmic drugs (AAD) was associated with a lower risk of the primary outcome, according to results of the VANISH2 trial.

Ablation 53

Ablation Tachycardia Cardiomyopathy Outcomes 53

Journal of the American Heart Association

DECEMBER 1, 2023

BackgroundThe incidence and type of complications following catheter ablation of atrial fibrillation have been extensively examined, but the impact associated with these complications on the length of stay and hospitalization costs is unknown.Methods and ResultsThis cohort study included 20 117 adult patients (mean age 62.6±11.4 years,

Atrial Fibrillation 72

Atrial Fibrillation Ablation Hospital Reimbursement 72

Journal of the American Heart Association

DECEMBER 8, 2023

Twenty‐six PVT/ventricular fibrillation–triggering PVCs were identified for ablation. After a mean follow‐up of 49 months after ablation, 8 (57%) patients were free from syncope recurrence. Ablation of trigger beat significantly reduced the syncope frequency (mean±SD, 4.3±1.6

Ablation 45

Ablation Tachycardia Electrophysiology Outcomes 45

Frontiers in Cardiovascular Medicine

MAY 1, 2024

BackgroundCatheter ablation is frequently used to manage recurrent atrial fibrillation (AF) resistant to drug therapy, with pulmonary vein isolation (PVI) as a key tactic. The reconnection of pulmonary veins was discovered primarily in the anterior region of the right superior PV and the superior portion of the left superior PV.

Atrial Fibrillation 52

Atrial Fibrillation Ablation Pulmonary Technology 52

Journal of Cardiovascular Electrophysiology

NOVEMBER 11, 2024

This study of 16 patients with persistent left superior vena cava (PLSVC) undergoing atrial fibrillation ablation shows a 66.7% identification rate of PLSVC-related triggers and an 85% success rate in acute isolation or targeted ablation. recurrence rate signals the need for enhanced outcomes in this challenging population.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outcomes Pulmonary 40

Frontiers in Cardiovascular Medicine

FEBRUARY 11, 2024

Despite the relative efficacy of ablation, the risk of AF recurrence is substantial, particularly in patients with persistent AF (perAF). At present we do not have any reliable intra-procedural electrophysiologic predictors of long-term success of AF ablation other than pulmonary vein isolation.

Pulmonary 64

Pulmonary Ablation Atrial Fibrillation Electrophysiology 64